NO991995L - Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav - Google Patents
Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger deravInfo
- Publication number
- NO991995L NO991995L NO991995A NO991995A NO991995L NO 991995 L NO991995 L NO 991995L NO 991995 A NO991995 A NO 991995A NO 991995 A NO991995 A NO 991995A NO 991995 L NO991995 L NO 991995L
- Authority
- NO
- Norway
- Prior art keywords
- vaccine compositions
- amino acid
- nucleic acid
- sequences related
- heliobacter pylori
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73915096A | 1996-10-28 | 1996-10-28 | |
| US75973996A | 1996-12-06 | 1996-12-06 | |
| US89192897A | 1997-07-14 | 1997-07-14 | |
| PCT/US1997/019575 WO1998018323A1 (en) | 1996-10-28 | 1997-10-28 | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO991995D0 NO991995D0 (no) | 1999-04-27 |
| NO991995L true NO991995L (no) | 1999-06-28 |
Family
ID=27419246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO991995A NO991995L (no) | 1996-10-28 | 1999-04-27 | Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973394A4 (id) |
| JP (1) | JP2001504329A (id) |
| KR (1) | KR20000052831A (id) |
| CN (1) | CN1235513A (id) |
| AR (1) | AR009600A1 (id) |
| AU (1) | AU734052B2 (id) |
| BR (1) | BR9712587A (id) |
| CA (1) | CA2265523A1 (id) |
| EE (1) | EE9900176A (id) |
| ID (1) | ID22065A (id) |
| IL (1) | IL129397A0 (id) |
| IS (1) | IS5005A (id) |
| NO (1) | NO991995L (id) |
| NZ (1) | NZ334568A (id) |
| PL (1) | PL333169A1 (id) |
| SA (1) | SA98180918A (id) |
| SK (1) | SK34699A3 (id) |
| TR (1) | TR199900940T2 (id) |
| WO (1) | WO1998018323A1 (id) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE244578T1 (de) * | 1993-07-27 | 2003-07-15 | Csl Ltd | Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit |
| US6406703B1 (en) | 1993-07-27 | 2002-06-18 | Csl Limited | Treatment of H. pylori associated gastroduodenal disease |
| DE19730425A1 (de) | 1997-07-16 | 1999-01-21 | Henkel Teroson Gmbh | Heißhärtende wäschefeste Rohbau-Versiegelung |
| EP1108033A2 (en) * | 1998-07-27 | 2001-06-20 | Aventis Pasteur Limited | $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| SE9901548D0 (sv) * | 1999-04-29 | 1999-04-29 | Astra Ab | Helicobacter pylori antigens |
| GB9914945D0 (en) * | 1999-06-25 | 1999-08-25 | Smithkline Beecham Biolog | Novel compounds |
| AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
| CN101532001A (zh) | 2000-03-08 | 2009-09-16 | 诺维信公司 | 具有改变的特性的变体 |
| GB0010370D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| GB0010371D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| WO2012124764A1 (ja) * | 2011-03-17 | 2012-09-20 | 国立大学法人三重大学 | 抗体の製造方法 |
| BR112018012033A2 (pt) * | 2015-12-14 | 2018-12-04 | Max Planck Gesellschaft | composição imunogênica e método para detectar infecção por h. pylori em um sujeito |
| CN115724922B (zh) * | 2022-07-19 | 2023-08-22 | 四川大学华西医院 | 一种幽门螺杆菌疫苗重组蛋白抗原TonB及其制备方法与应用 |
| CN115581201A (zh) * | 2022-08-26 | 2023-01-10 | 云南省农业科学院花卉研究所 | 以茎段为外植体诱导的二倍体月季f1-61的植株再生方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9300139L (sv) * | 1993-01-19 | 1994-07-20 | Medicarb Ab | Framställning av ett nytt läkemedel |
-
1997
- 1997-10-28 TR TR1999/00940T patent/TR199900940T2/xx unknown
- 1997-10-28 EP EP97913847A patent/EP0973394A4/en not_active Withdrawn
- 1997-10-28 PL PL97333169A patent/PL333169A1/xx unknown
- 1997-10-28 KR KR1019990703660A patent/KR20000052831A/ko not_active Application Discontinuation
- 1997-10-28 JP JP52071098A patent/JP2001504329A/ja active Pending
- 1997-10-28 AU AU50933/98A patent/AU734052B2/en not_active Ceased
- 1997-10-28 NZ NZ334568A patent/NZ334568A/xx unknown
- 1997-10-28 ID IDW990160A patent/ID22065A/id unknown
- 1997-10-28 SK SK346-99A patent/SK34699A3/sk unknown
- 1997-10-28 EE EEP199900176A patent/EE9900176A/xx unknown
- 1997-10-28 WO PCT/US1997/019575 patent/WO1998018323A1/en not_active Application Discontinuation
- 1997-10-28 CN CN97199233A patent/CN1235513A/zh active Pending
- 1997-10-28 CA CA002265523A patent/CA2265523A1/en not_active Abandoned
- 1997-10-28 AR ARP970105002A patent/AR009600A1/es not_active Application Discontinuation
- 1997-10-28 BR BR9712587-3A patent/BR9712587A/pt not_active IP Right Cessation
- 1997-10-28 IL IL12939797A patent/IL129397A0/xx unknown
-
1998
- 1998-02-28 SA SA98180918A patent/SA98180918A/ar unknown
-
1999
- 1999-03-18 IS IS5005A patent/IS5005A/is unknown
- 1999-04-27 NO NO991995A patent/NO991995L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000052831A (ko) | 2000-08-25 |
| SK34699A3 (en) | 2000-04-10 |
| SA98180918A (ar) | 2005-12-03 |
| JP2001504329A (ja) | 2001-04-03 |
| PL333169A1 (en) | 1999-11-22 |
| BR9712587A (pt) | 1999-10-26 |
| NO991995D0 (no) | 1999-04-27 |
| WO1998018323A1 (en) | 1998-05-07 |
| AU734052B2 (en) | 2001-05-31 |
| EP0973394A4 (en) | 2005-03-30 |
| AU5093398A (en) | 1998-05-22 |
| AR009600A1 (es) | 2000-04-26 |
| NZ334568A (en) | 2000-04-28 |
| CA2265523A1 (en) | 1998-05-07 |
| IL129397A0 (en) | 2000-02-17 |
| EP0973394A1 (en) | 2000-01-26 |
| ID22065A (id) | 1999-08-26 |
| IS5005A (is) | 1999-03-18 |
| EE9900176A (et) | 1999-12-15 |
| TR199900940T2 (xx) | 1999-09-21 |
| CN1235513A (zh) | 1999-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991995L (no) | Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav | |
| GB2181138B (en) | Recombinant alveolar surfactant protein | |
| AR006188A1 (es) | "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion". | |
| DE69129865T2 (de) | Osteogene peptide | |
| NZ332565A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| NO992158L (no) | Nukleinsyre- og aminosyresekvenser forbundet med Heliobacter Pylori og vaksinepreparater av disse. | |
| DK312787A (da) | Polypeptider, fremgangsmaade til deres fremstilling, dna som koder for polypeptiderne, vektorer indeholdende saadanne gensekvenser og laegemidler indeholdende polypeptiderne | |
| DK0463053T3 (da) | Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener | |
| DE3650035T2 (de) | THF-Zusammensetzungen. | |
| EP0317279A3 (en) | Peptides for use in the purification of factor viii | |
| CA2004764A1 (en) | Ancrod proteins, their preparation and use | |
| MX9709846A (es) | Secuencias de acidos nucleico y aminoacidos relacionados con el helicobacter pylori para procedimientos de diagnostico y terapeuticos. | |
| DK0540560T3 (da) | Ancrod-lignende proteiner, fremstilling og anvendelse deraf | |
| DK56995A (da) | Rekombinante lymphotoxin-varianter | |
| DK200200302A (da) | Rekombinante polypeptider omfattende aminosyresekvensen af moden vævsfaktorinhibitor (TFI), polypeptidfragmenter deraf, ekspressionsvektorer der koder for disse, værtsceller transformeret dermed, og fremgangsmåde til fremstilling af et ........ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |